ZA926374B - Pharmaceutical agents. - Google Patents

Pharmaceutical agents.

Info

Publication number
ZA926374B
ZA926374B ZA926374A ZA926374A ZA926374B ZA 926374 B ZA926374 B ZA 926374B ZA 926374 A ZA926374 A ZA 926374A ZA 926374 A ZA926374 A ZA 926374A ZA 926374 B ZA926374 B ZA 926374B
Authority
ZA
South Africa
Prior art keywords
methyl
pharmaceutical agents
physical
trifluorobutylcarbamoyl
dol
Prior art date
Application number
ZA926374A
Other languages
English (en)
Inventor
Murray Watson Cuthbert
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA926374B publication Critical patent/ZA926374B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA926374A 1991-09-05 1992-08-24 Pharmaceutical agents. ZA926374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (1)

Publication Number Publication Date
ZA926374B true ZA926374B (en) 1993-03-05

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA926374A ZA926374B (en) 1991-09-05 1992-08-24 Pharmaceutical agents.

Country Status (21)

Country Link
US (2) US5352694A (ja)
EP (1) EP0531078B1 (ja)
JP (1) JP2914414B2 (ja)
KR (1) KR100254710B1 (ja)
AT (1) ATE138910T1 (ja)
AU (1) AU646587B2 (ja)
CA (1) CA2076722A1 (ja)
CZ (1) CZ281999B6 (ja)
DE (1) DE69211258T2 (ja)
DK (1) DK0531078T3 (ja)
FI (1) FI102372B1 (ja)
GB (2) GB9119001D0 (ja)
HK (1) HK18297A (ja)
HU (2) HU213410B (ja)
IL (1) IL102856A (ja)
NO (1) NO178370C (ja)
NZ (1) NZ244016A (ja)
RU (1) RU2095348C1 (ja)
SK (1) SK267092A3 (ja)
TW (1) TW302359B (ja)
ZA (1) ZA926374B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) * 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
DE602005023797D1 (de) 2004-07-14 2010-11-04 Inflammation Res Ct Co Ltd Verfahren zur Hemmung von Tumormetastasierung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)

Also Published As

Publication number Publication date
NO923467L (no) 1993-03-08
GB9119001D0 (en) 1991-10-23
SK279657B6 (sk) 1999-02-11
KR100254710B1 (ko) 2000-05-01
IL102856A0 (en) 1993-01-31
HU210879A9 (en) 1995-09-28
CZ281999B6 (cs) 1997-04-16
HK18297A (en) 1997-02-13
HU9202660D0 (en) 1992-10-28
TW302359B (ja) 1997-04-11
AU2101292A (en) 1993-03-11
CA2076722A1 (en) 1993-03-06
DE69211258T2 (de) 1996-10-02
NZ244016A (en) 1995-01-27
NO923467D0 (no) 1992-09-04
DE69211258D1 (de) 1996-07-11
CZ267092A3 (en) 1993-03-17
HU213410B (en) 1997-06-30
FI102372B (fi) 1998-11-30
FI923869A0 (fi) 1992-08-28
NO178370B (no) 1995-12-04
JP2914414B2 (ja) 1999-06-28
US5466826A (en) 1995-11-14
EP0531078A1 (en) 1993-03-10
EP0531078B1 (en) 1996-06-05
JPH05194385A (ja) 1993-08-03
DK0531078T3 (da) 1996-10-14
NO178370C (no) 1996-03-13
US5352694A (en) 1994-10-04
ATE138910T1 (de) 1996-06-15
IL102856A (en) 1996-12-05
FI923869A (fi) 1993-03-06
GB9216774D0 (en) 1992-09-23
HUT69696A (en) 1995-09-28
FI102372B1 (fi) 1998-11-30
AU646587B2 (en) 1994-02-24
SK267092A3 (en) 1999-02-11
RU2095348C1 (ru) 1997-11-10
KR930005976A (ko) 1993-04-20

Similar Documents

Publication Publication Date Title
AU683442B2 (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
GR3017996T3 (en) 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
NZ242104A (en) Amides of aminoethylsubstituted benzothiazole, -thiazine, -oxazole and -oxazine derivatives; pharmaceutical compositions thereof
HUT54705A (en) Process for producing 11 beta-aryl-4-estrenes and pharmaceutical compositions comprising same
AU5204093A (en) Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
HK83697A (en) Methanoanthracenes as dopamine antagonists
ZA926374B (en) Pharmaceutical agents.
HUT50325A (en) Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient
MY137475A (en) Chemical compounds.
HUT60710A (en) Process for producing new substituted amine compounds
AU2101792A (en) Methanoanthracene D2 dopamine antagonists
HUT55033A (en) Process for producing aminooligohydroxy derivatives and pharmaceutical compositions comprising same
EP0375450A3 (en) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo(2.2.1) heptane, process for its preparation and pharmaceutical compositions containing it
IL106934A (en) Heteroarenylpiperazines a process for their preparation and pharmaceutical compositions comprising them
IL109227A0 (en) Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments